We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Thrombophilic Risk Factors in Pediatric Patients Diagnosed at the Ha'Emek Medical Center

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00736008
First Posted: August 15, 2008
Last Update Posted: August 26, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr Koren Ariel, HaEmek Medical Center, Israel
  Purpose

The study will assess the clinical and laboratory data of about 100 pediatric patients diagnosed and treated at the Pediatric Hematology Unit during the years 1980 until 2007 because of thrombotic events.

The results, the treatment given, and the outcome of the patients will be summarized.


Condition Intervention
Thrombosis Other: Observational

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Study Will Summarize the Clinical and Laboratory Data of All the Pediatric Patients Diagnosed With Thrombotic Events at the Pediatric Hematology Unit

Resource links provided by NLM:


Further study details as provided by Dr Koren Ariel, HaEmek Medical Center, Israel:

Estimated Enrollment: 100
Study Start Date: May 2008
Study Completion Date: August 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
A
Patients with thromboembolic events
Other: Observational
Data summary only

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 20 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The population cohort will include about 100 patients diagnosed with thrombotic events at the Pediatric Hematology Unit
Criteria

Inclusion Criteria:All the patients diagnosed since 1980.

Exclusion Criteria:Patients with insufficient data records.

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00736008


Locations
Israel
Pediatric Hematology Unit - Ha'Emek Medical Center
Afula, Israel, 18101
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Principal Investigator: Carina Levin, MD Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel
Principal Investigator: Ayala Mari, Student Pediatric Dpt B - Ha'Emek Medical Center - Afula - Israel
  More Information

Responsible Party: Dr Koren Ariel, Head of Pediatric Hematology Unit and Pediatric Dpt B, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier: NCT00736008     History of Changes
Other Study ID Numbers: 0020-08-EMC
First Submitted: August 14, 2008
First Posted: August 15, 2008
Last Update Posted: August 26, 2011
Last Verified: August 2011

Keywords provided by Dr Koren Ariel, HaEmek Medical Center, Israel:
Factor V Leiden
Prothrombin Mutation
Hypercoagulability
Pediatrics

Additional relevant MeSH terms:
Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases